SCHEMBL24813309

SCHEMBL24813309

c1ccc(-c2ccc3c(-c4ccc5ccccc5c4)c4cc(-c5ccccc5)ccc4c(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)c3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
GRIA1 P42261 1/20 0.44
CACNG8 Q8WXS5 1/20 0.44
CACNG2 Q9Y698 1/20 0.44
MAPK10 P53779 6/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HSP90AA1 P07900 1/20 0.42
MAPT P10636 1/20 0.42
PTGER4 P35408 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
PTGS2 P35354 1/20 0.40
RECQL P46063 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17755350 0.99 ESR1 (0.49) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL25668081 0.99 ESR1 (0.49) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL17755355 0.99 ESR1 (0.49) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL24813302 0.99 ESR1 (0.49) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL18999456 0.99 ESR1 (0.51) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL25668125 0.98 ESR1 (0.53) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12571663 0.98 ESR1 (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12571687 0.98 ESR1 (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL11953894 0.98 ESR1 (0.49) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL17932821 0.97 ESR1 (0.52) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209998-A1 ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-29 US disclosed
US-20230209998-A1 ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-29 US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 ESR1 13/4885ESR2 26/4885GRIA1 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.